510(k) Report

510(k) · Cleared

Recalled · Class II · 2018

0.9% Sodium Chloride Injection, USP - 2.5 mL in 3 mL Syringe, 0.9% Sodium Chloride Injection, USP-3mL in 10 mL Syringe, 0.9% Sodium Chloride Injection, USP - 5 mL in 10 mL Syringe, 0.9% Sodium Chloride Injection, USP - 10 mL in 10 mL Syringe

K142620510(k) TraditionalCleared Dec 12, 201487-day reviewClass II21 CFR 880.5200Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Excelsior Medical Corporation · NGT Saline, Vascular Access Flush

Cleared on Dec 12, 2014 as substantially equivalent to K962938 (Excelsior Medical Corp., 1996) and 1 other predicate after an 87-day review. Its family tree reaches back 2 generations to 2005. It has been recalled once.

Decided
Dec 12, 2014
Review
87 days
Class
Class II
Product code
NGT
Recalls
1
Predicates
2

Its longest line of descent runs back 2 generations to K053120 (2005). 3 ancestors in all, the oldest K962938 (1996). No later device cites it as a predicate yet.

  1. Root · 2 generations backK053120 Sterile Field Saline and Heparin Lock Flush SyringesExcelsior Medical Corp. · 2005 · Recalled
  2. 1 generation backK082837 Sterile Field Saline Pre-Filled Syringe (S)Excelsior Medical Corp. · 2008 · Recalled
  3. This deviceK142620 0.9% Sodium Chloride Injection, USP - 2.5 mL in 3 mL Syringe, 0.9%…Excelsior Medical Corporation · 2014
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K053120Sterile Field Saline and Heparin Lock Flush SyringesExcelsior Medical Corp.20051
−1K082837Sterile Field Saline Pre-Filled Syringe (S)Excelsior Medical Corp.20081
0 (this device)K1426200.9% Sodium Chloride Injection, USP - 2.5 mL in 3 mL Syringe, 0.9% Sodium…Excelsior Medical Corporation2014—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199610
FIG. 1 — Lineage of K142620, 2005–2014Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NGT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NGT device

  1. #1 K250884 0.9 % Sodium Chloride Injection, USP, BD…score 11.6 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K962938Excelsior Disposable Syringe W/Normal Saline (.9% Sodium Chloride)
Summary page 4
…lated to intended use, design, and material characteristics: • Excelsior Disposable Syringe W/Normal Saline (0.9% Sodium Chloride), Excelsior Medical Corp., K962938 • Sterile Field Saline Flush Syringe(s), Excelsior Medical Corporation, K082837 Description of the Device Excelsior Medica…
Excelsior Medical Corp.19961
*K082837Sterile Field Saline Pre-Filled Syringe (S)
Summary page 4
…able Syringe W/Normal Saline (0.9% Sodium Chloride), Excelsior Medical Corp., K962938 • Sterile Field Saline Flush Syringe(s), Excelsior Medical Corporation, K082837 Description of the Device Excelsior Medical Corporation’s 0.9% Sodium Chloride Injection, USP prefilled syringe products are pr…
Excelsior Medical Corp.20081

Also cleared against K962938: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Feb 1, 2018Class IIZ-2948-2018Employee errorPackaged with an incorrect overwrap.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 9 years and passes through 2 companies; a new generation was cleared every 6.0 years on median.
  • 3 of the 3 ancestors have a recall of any class.
  • 1 other device also cites its predicate K962938.

How does its category compare?

All NGT devices

NGT Saline, Vascular Access Flush: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.

FDA decisions per year · NGT

1in 2025

2008: 12009: 12010: 22011: 32012: 42013: 12014: 32015: 12016: 12017: 22018: 12019: 22020: 22022: 32023: 62024: 12025: 1
2007high 6 (2023) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NGT

142in 2023

2011: 219 days median2012: 106 days median2014: 87 days median2022: 151 days median2023: 142 days median
2007high 219 (2011) · low 87 (2014)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NGT

1in 2025

2007: 22009: 12010: 72011: 12012: 12013: 1, 1 Class I2016: 1, 1 Class I2019: 22021: 1, 1 Class I2022: 12023: 3, 2 Class I2025: 12026 (partial year): 1, 1 Class I
2007high 7 (2010) · low 0 (2008)2026

Class I (6 since 2007) Class II/III not classified

Adverse event reports per year · NGT

212in 2025

2007: 312008: 642009: 182010: 232011: 202012: 52013: 252014: 252015: 142016: 822017: 562018: 2702019: 3402020: 3222021: 5662022: 2822023: 3132024: 3322025: 212
2007high 566 (2021) · low 5 (2012)2025

MAUDE reports naming product code NGT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—231
20081—064
20091—118
20102—723
20113219120
2012410615
20131—1 (1)25
2014387025
20151—014
20161—1 (1)82
20172—056
20181—0270
20192—2340
20202—0322
20210—1 (1)566
202231511282
202361423 (2)313
20241—0332
20251—1212
20260—1 (1)—

What is it indicated for?

0.9% Sodium Chloride Injection, USP prefilled syringes are intended for flushing of IV catheters and IV tubing only.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K142620: 0.9% Sodium Chloride Injection, USP - 2.5 mL in 3 mL Syringe, 0.9% Sodium Chloride Injection, USP-3mL in 10 mL Syringe, 0.9% Sodium Chloride Injection, USP - 5 mL in 10 mL Syringe, 0.9% Sodium Chloride Injection, USP - 10 mL in 10 mL Syringe.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K142620

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026